⁉️ We are excited to welcome Jurgi, our new ICEX VIVES fellow, who will be collaborating with PROGEN in Heidelberg-Germany, to support the commercial efforts of DIVERSA’s advanced lipid nanoparticles for drug delivery and gene therapy 🧬 #Innovation #Biotechnology #Nanotechnology

🚀 DIVERSA is attending key pharma & biotech events: 📍 CPHI: Oct 8-10, Milan 📍 Festival of Biologics: Oct 15-17, Basel 📍 BIO-Europe: Nov 4-5, Stockholm 📍 Cell & Gene Therapy: Dec 1-4, Dublin Catch us at CPHI Milan next week! 📩Subscribe for updates 👉 ttps://shorturl.at/ZuQRV

🚀 Advanced technologies are revolutionizing drug development! AI, nanotechnology, organoids, and organ-on-a-chip models are transforming the future of medicine. Learn more in our latest article 👉 diversatechnologies.com/advancing-drug…

CPHI is starting TODAY in Milan! 🇮🇹 💼Our Business Developer is representing DIVERSA Technologies. If you’re attending, don’t miss the chance to learn about our innovative solutions in nanoparticle formulation and drug delivery! 💊

🎉Excited for the Festival of Biologics 2024 in Basel! At DIVERSA, we're ready to enhance your biomolecules with our Lipid Nanoparticles Platform. Don’t miss the chance to explore new collaborations 👉 Book a meeting through the partnering website or visit us at Stand #S32! ✨

🌟Nanotechnology is revolutionizing protein therapeutics and drug delivery! Our blog shows how nanoparticles enhance stability, targeting, and delivery of protein drugs, enabling better precision medicines and combination therapies! Read more👉 diversatechnologies.com/?p=3085&previe…

🌟Our Project & Innovation Manager, Sara Vicente, has received the prestigious grant "Ayudas Torres Quevedo" for her project on "Nanotecnología para edición genética en el ámbito de la inmuno-oncología" This recognition highlights her talent and DIVERSA’s dedication to science.

🚀Excited for BIO-Europe 2024! Join us in Stockholm from November 4-6. At DIVERSA, we'll showcase our Lipid Nanoparticles to enhance your biomolecule delivery 🧬💊 Meet our Business Development Manager, Guillermo Calvo, to learn how our technology can transform your projects

DIVERSA Technologies has been awarded the Innovative SME Seal 🏅 by the Spanish Ministry of Science, Innovation, and Universities for our strong R&D+i activity. This recognition highlights our technical expertise, funded projects, and patents. Thank you to our team and partners!

We’re excited to announce that DIVERSA has secured a €150,000 loan from enisa ! 🎉 This funding will accelerate our cutting-edge nanotherapeutics, bringing us closer to addressing unmet clinical needs. Stay tuned for more updates! 🚀 #Innovation #ENISA #Growth #DIVERSAnews #SME

Happy Holidays from DIVERSA! May your year be as bright as our fluorescent nanoparticles and as promising as our innovations. ✨🔬 #Innovation #HappyNewYear2025

📢 DIVERSA has received the CPP2023-010787 (Ministerio de Ciencia, Innovación y Universidades) grant for the INCANTA project! 🎯 We’re partnering with Pedro Berraondo from Cima Universidad de Navarra and Jenifer García from Instituto de Invest. Sanitaria de Santiago (IDIS) to develop innovative mRNA-based therapies for advanced cancer. 🌟 #Cancer #mRNA #Innovation

🚀 We’re Hiring! Here at DIVERSA Technologies, we continue to grow! We are looking for an Experienced Research #Scientist to join our team! 🗓 Deadline to Apply: January 7th, 2025 📩 Send your CV to: [email protected] #Openposition #Nanotechnology #Nanoparticles

DIVERSA Technologies has been selected for the prestigious Universidad de Navarra Incubator! 🚀 This program connects us with top clinical experts, investors, and resources to accelerate innovation in health & life sciences. Stay tuned! 🔬💡 #HealthCareInnovation #StartupSuccess #Nanomedicine

Happy New Year! As we step into a brand-new year, DIVERSA renews its commitment to advancing innovative solutions in healthcare through cutting-edge #nanotechnology. Let’s make 2025 a year to remember, filled with progress and meaningful breakthroughs in healthcare innovation!

🎉 Great news: Mónica Escobar, our FEUGA scholar, is starting her Industrial PhD at DIVERSA, funded by the DIN 2024 program through the Agencia Estatal de Investigación (MICIU/AEI /10.13039/501100011033). 🚀💡 #Innovation #IndustrialPhD #TeamDIVERSA #Science

Our project "NocTURNA" has secured funding under the "Multi-PAÍS" call! In collaboration with Prof. Paulo Bettencourt (UCP), a leader in mRNA vaccines for TB, we're pushing boundaries in health innovation. 🚀 Funded by @CDTI_innovacion , Ministerio de Ciencia, Innovación y Universidades #Innovation #mRNAVaccines

Cancer awareness: Beyond the day, towards action. At DIVERSA, we go beyond conversations—we drive impact at the intersection of science & technology. From novel therapies to efficient drug delivery, we're accelerating breakthroughs in cancer treatment. #WorldCancerDay

🎗️ Nano Cancer Research Day unites experts in #Nanomedicine to drive real impact! 🚀🔬 As NanomedSpain members, DIVERSA advances nanotech solutions for cancer treatment with clinical & industry leaders. 💡🤝 🔗 More info: NDCC – 2025 – NANOMED Spain #NanoOncology #NDCC2025

What do these biotech #startups have in common? ⬇️ 🔹 DIVERSA Technologies – Developing lipid-based nanoparticle delivery systems for pharma and biotech. A promising spin-off from Instituto de Invest. Sanitaria de Santiago (IDIS) and SERGAS